Resources

8 Resources for

china and mike havrilla

  • Subscribe to this listing via:
  • RSS
  • Email

BNET Resources

NIVS IntelliMedia Group: Recent IPO, Solid Revenue Growth
Mike Havrilla submits: NIVS IntelliMedia Technology Group NIV develops, produces and sells audio and video equipment and set-top box products. The company has developed an established brand name in China with a customer base that of wholesalers and distributors of electronic products on a brand name as well as an...
Tags: China, Gadgets, Mike Havrilla
External links 2009-03-21
NIVS IntelliMedia Technology: Strong Results, Solid Outlook
Mike Havrilla submits: NIVS IntelliMedia Technology Group NIV reported its 4Q and FY08 financial results yesterday after the market close. The Company develops, produces and sells audio and video equipment and set-top box products under an established brand name in China with a customer base that includes both wholesalers and...
Tags: China, Mike Havrilla
External links 2009-04-01
NIVS IntelliMedia Earnings Review
Mike Havrilla submits: NIVS IntelliMedia Technology Group (AMEX:NIV) filed its SEC form 10-Q after the market close on 5/19/09, which included a summary of 1Q09 financial results. The Company develops, produces and sells audio and video equipment and set-top box products under an established brand name in China with a...
Tags: Gadgets, China, Mike Havrilla
External links 2009-05-20
NF Energy: Growth Play on China Clean Energy Infrastructure
Mike Havrilla submits: NF Energy Savings Corp. (NFES.OB) is a manufacturer and service provider for the improvement of energy efficiency and the reduction of emissions in China. NFES is a leading provider of wind cogeneration equipment and flow control systems for coal, hydro, and nuclear cogeneration facilities with 20-30% market...
Tags: China, Mike Havrilla
External links 2009-07-25
NF Energy: 2Q Results Exceed Growth Estimates
Mike Havrilla submits: Since I first wrote about NF Energy Savings Corp. (NFES.OB) in late July as a growth play on clean energy infrastructure in China, the stock price has increased by over 60% thanks to new deal flow and strong 2Q09 results yesterday. NF Energy is a manufacturer...
Tags: China, Mike Havrilla
External links 2009-08-12
NeoStem: A 3-Part China Merger Strategy
Mike Havrilla submits: NeoStem (AMEX: NBS) is an innovator and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications that is expanding into research, medical tourism, and China for the commercialization of anti-aging / cosmetic medicine...
Tags: China, Mike Havrilla, NeoStem Inc.
External links 2009-10-08
NF Energy: Continuing Its Robust Growth
Mike Havrilla submits: NF Energy Saving Corp. (OTC: NFEC.OB) provides emission reduction and energy saving equipment / services for China’s rapidly growing cogeneration sector. The Company also manufactures wind power equipment and flow control systems for coal, hydro, and nuclear cogeneration facilities with an additional wind energy infrastructure manufacturing plant...
Tags: China, Energy, Mike Havrilla
External links 2009-10-19
NeoStem: Start of a New Era
Mike Havrilla submits: NeoStem (AMEX: NBS) [click on preceding link for the company’s news room website] is an innovator and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications that is expanding into research, medical tourism,...
Tags: China, Biotech, Mike Havrilla, NeoStem Inc.
External links 2009-12-17

Additional Resources

China Medical Embraces Molecular Diagnostics
Mike Havrilla submits: China Medical CMED offers a compelling value since losing about 60% of its market value in the past year, with shares trading very close to August 2005 IPO levels at the close yesterday of under 18 bucks click on chart to enlarge. CMED is also included in...
Tags: Biotech, Healthcare, Mike Havrilla, Sequenom Inc.
External links 2008-12-25
NeoStem: Pending Merger Key to China Growth Strategy
Mike Havrilla submits: NeoStem (AMEX: NBS) is an innovator and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem...
Tags: Biotech, Healthcare, Mike Havrilla, NeoStem Inc.
External links 2009-09-16
NeoStem: Expanding Beyond Stem Cell Banking
Mike Havrilla submits: NeoStem (AMEX:NBS) is a pioneer and leader in the pre-disease collection, processing and long-term storage of adult stem cells for the general population to use in future medical applications. The Company's business model includes generating revenue through ongoing fees associated with a minimally invasive, proprietary stem cell...
Tags: Biotech, Healthcare, Mike Havrilla, NeoStem Inc.
External links 2009-05-18
Access Pharma Provides an Update on ProLindac Development
Mike Havrilla submits: On 8/3/09, Access Pharma (ACCP.OB) provided an update on its clinical development strategy for ProLindac, a novel DACH platinum drug that has shown to be active in many solid tumors in human clinical studies. Access has commenced a new clinical study of ProLindac in France. The...
Tags: Biotech, Mike Havrilla
External links 2009-08-03
NF Energy: Speculative Buy, $8 Target
Mike Havrilla submits: NF Energy Saving Corp. (NFEC.OB) is a provider of integrated energy conservation solutions utilizing energy-saving equipment, technical services and energy management solutions. Research Analyst Ira Zadikow of Pro-Active Research Group issued an initiation of coverage report on 8/28/09 with a speculative buy rating and $8/share long-term price...
Tags: Energy, Mike Havrilla
External links 2009-09-01
Access Pharma: ProLindac, MuGard Updates
Mike Havrilla submits: On 9/10/09, Access Pharma (ACCP.OB) announced that its clinical development team recently met with its partners Aosaikang Medicinal Group (ASK) in China and JCOM, Ltd. JCOM in Korea, along with key opinion leaders in oncology indications to discuss the protocols for the three planned ProLindac combination studies....
Tags: Biotech, Healthcare, Mike Havrilla
External links 2009-09-12
  • << Previous
  • page 1 of 1
  • Next >>
advertisement
advertisement